Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 34,800
+1,450 (4.35%)
At close: Oct 2, 2025
Hanall Biopharma Market Cap
Hanall Biopharma has a market cap or net worth of 1.75 trillion as of October 6, 2025. Its market cap has decreased by -4.08% in one year.
Market Cap
1.75T
Enterprise Value
1.74T
Revenue
150.09B
Ranking
n/a
PE Ratio
784.06
Stock Price
34,800.00
Market Cap Chart
Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.75T, an increase of 6,558.13%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,751.04B | -10.66% |
| Dec 30, 2024 | 1,959.95B | -12.72% |
| Dec 28, 2023 | 2,245.71B | 148.89% |
| Dec 29, 2022 | 902.29B | -16.29% |
| Dec 30, 2021 | 1,077.89B | -43.84% |
| Dec 30, 2020 | 1,919.22B | 3.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |